# Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration

> **NCT06024148** · — · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 250 (estimated)

## Conditions studied

- Osteoporosis Fracture

## Interventions

- **OTHER:** phone survey

## Key facts

- **NCT ID:** NCT06024148
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09
- **Primary completion:** 2024-02
- **Final completion:** 2024-09
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06024148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06024148, "Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06024148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*